Company or ticker...

Oruka Therapeutics

Oruka develops antibody drugs for chronic skin and inflammatory diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ORKA

5.5B

0.0

n/a

198.91%

Key Facts

M. Cap

PS

PE

YTD

5.5B

0.0

n/a

198.91%

10MA

20MA

50MA

200MA

$ORKA